// App-Quantinova.ai

: Serum Levels of Club-Cell Protein 16 (CC-16), Surfactant Protein D (SPD), soluble Receptor of Glycation End-products (sRAGE), Fibrinogen and C-Reactive Protein (CRP) and FEV1 Decline, Exacerbations and Mortality in SUMMIT

Researchers

Presenter

  • Bartolome R. Celli

Principal Investigators

  • Julie Anderson

  • Robert Brook

  • Courtney Crim

  • Peter Calverley

  • Ian Dixon

  • Victor Kim

  • Fernando Martinez

  • Andrea Morris

  • David Newby

  • Julie Yates

  • Jrgen Vestbo

Medical Centers

  • Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston, United States of America

  • GSK, Stockley Park, United Kingdom

  • University of Michigan Health System, Ann Arbor, MI, United States,

  • NIH/NIEHS, Research Triangle Park, United States of America

  • University Hospital Aintree, Liverpool, United Kingdom

  • Veramed Ltd, Twickenham, United Kingdom,

  • Temple University School of Medicine, Philadelphia, Pennsylvania, United States

  • NewYork-Presbyterian Hospital/Weill Cornell Medical Center, New York, United States of America

  • University of Manchester, Manchester, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Nucleoside diphosphate kinase A

  • C reactive protein

  • Fibrinogen

  • Surfactant Protein D

Drug/Treatment

  • Fluticasone furoate

  • Fibrinogen (IV)

Outcome

  • N/A


Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A